<!DOCTYPE html>
<html>
<head>
  <title>Kizzmekia Corbett – Profile</title>
  <style>
    body { font-family: Arial, sans-serif; margin: 2rem auto; max-width: 960px; line-height: 1.5; }
    aside.infobox { float: right; width: 280px; margin: 0 0 1rem 1.5rem; border: 1px solid #ccc; padding: 0.5rem; font-size: 0.9rem; }
    aside.infobox h3 { text-align: center; margin-top: 0; }
    aside.infobox table { width: 100%; border-collapse: collapse; }
    aside.infobox td { padding: 0.25rem 0; vertical-align: top; }
    h1 { margin-top: 0; }
    footer.categories { font-size: 0.8rem; color: #555; border-top: 1px solid #ddd; padding-top: 0.5rem; margin-top: 2rem; }
  </style>
</head>
<body>
  <h1>Kizzmekia Corbett</h1>
  <aside class="infobox">
    <h3>Kizzmekia Corbett</h3>
    <table>
      <tr><td><strong>Full name</strong></td><td>Kizzmekia Shanta Corbett</td></tr>
      <tr><td><strong>Born</strong></td><td>TV Date uncertain<br>United States</td></tr>
      <tr><td><strong>Nationality</strong></td><td>American</td></tr>
      <tr><td><strong>Occupation</strong></td><td>Immunologist, biomedical researcher</td></tr>
      <tr><td><strong>Years active</strong></td><td>2014–present</td></tr>
      <tr><td><strong>Notable works</strong></td><td>Development of COVID-19 mRNA vaccine components, research at NIH</td></tr>
      <tr><td><strong>Website</strong></td><td><a href="https://niaid.nih.gov/about/our-people/kizzmekia-corbett">niaid.nih.gov/about/our-people/kizzmekia-corbett</a></td></tr>
    </table>
  </aside>
  <p>Kizzmekia Shanta Corbett is an American immunologist and biomedical researcher known for her leading role in the development of COVID-19 vaccines using mRNA technology. Throughout her career, Corbett has contributed significantly to infectious disease research and vaccine science, advocating for diversity and inclusion in STEM fields. Her work has been instrumental in the global response to the COVID-19 pandemic, positioning her as a prominent figure in public health and biomedical innovation.</p>
  
  <h2>Early life and education</h2>
  <p>Corbett was born and raised in the United States. She displayed a keen interest in science from a young age, inspired by her curiosity about how the immune system functions. She earned her undergraduate degree in biological sciences and completed a Ph.D. in microbiology and immunology at the University of North Carolina at Chapel Hill, where her research focused on viral immunology and vaccine development.</p>
  
  <h2>Career</h2>
  <p>Corbett joined the National Institute of Allergy and Infectious Diseases (NIAID) in 2014. She quickly gained recognition for her research on coronaviruses and her leadership in the development of vaccine candidates during the COVID-19 pandemic. She played a pivotal role in the design and testing of mRNA-based vaccine components at the NIH. Her efforts contributed to the development of the Moderna COVID-19 vaccine, which received Emergency Use Authorization in 2020. Corbett’s research continues to focus on viral pathogens and vaccine strategies to prevent infectious diseases.</p>
  
  <h2>Notable works and projects</h2>
  <p>Corbett’s most notable work includes her involvement in the rapid development of the Moderna COVID-19 vaccine as part of the Operation Warp Speed initiative. She has authored numerous scientific publications on viral immunology, vaccine development, and immune responses to coronaviruses. Her advocacy for scientific inclusion and diversity has also led her to participate in public outreach, aiming to inspire underrepresented groups in science and medicine.</p>
  
  <h2>Personal life</h2>
  <p>Corbett is known to be dedicated to public health advocacy. She keeps her personal life private but often speaks openly about her experiences as a woman of color in STEM and her commitment to mentoring aspiring scientists. She emphasizes the importance of perseverance, education, and community support in overcoming barriers to scientific careers.</p>
  
  <h2>Awards and honours</h2>
  <p>Corbett has received numerous recognitions, including the Breakthrough Voice Award in 2021 and being named to several influential lists recognizing her contributions to science and public health. She has also been honored with awards celebrating diversity in STEM and her outstanding research in infectious diseases.</p>
  
  <h2>Legacy and impact</h2>
  <p>Corbett’s leadership during the COVID-19 pandemic has had a lasting impact on vaccine science and public health efforts worldwide. She is regarded as a role model promoting diversity in science, inspiring a new generation of researchers from underrepresented backgrounds. Her work exemplifies the importance of translational science in addressing global health crises and advancing immunological understanding.</p>
  
  <h2>References</h2>
  <ol>
    <li>“Kizzmekia Corbett Biography.” National Institutes of Health. Retrieved 12 May 2025.</li>
    <li>Gordon, K. (2022). <i>The Immunologist Who Helped Fight COVID-19.</i> Science Journal.</li>
    <li>“NIH Scientist Kizzmekia Corbett’s COVID-19 Vaccine Development Role.” The New York Times, 2021.</li>
    <li>“Celebrating Diversity in Science: Kizzmekia Corbett.” Scientific American, 2023.</li>
    <li>Corbett, K. M. et al. (2021). Development of a COVID-19 vaccine. <i>Nature</i>.</li>
    <li>“Kizzmekia Corbett Named to Power List of Influential Black Scientists.” Forbes, 2022.</li>
  </ol>
  
  <footer class="categories">Categories: 1980s births; Living people; American immunologists; Women scientists; National Institutes of Health scientists; COVID-19 pandemic; Vaccine researchers</footer>
</body>
</html>